Bilateral Idiopathic Adrenal Hyperplasia: Genetics and Beyond

Area of Science:

• Endocrinology
• Genetics
• Internal Medicine

Background:

• Bilateral adrenal hyperplasia (BAH) constitutes a significant portion of primary aldosteronism cases.
• BAH presents a key target for medical management compared to surgically treated unilateral forms.
• While most primary aldosteronism is sporadic, familial forms linked to germline mutations exist.

Purpose of the Study:

• To review current knowledge on the genetic basis of bilateral adrenal hyperplasia.
• To identify gaps in understanding the genetic contribution to BAH and population-level renin/aldosterone levels.
• To highlight future research directions, including genome-wide association studies.

Main Methods:

• Literature review of genetic studies on primary aldosteronism and bilateral adrenal hyperplasia.
• Analysis of recent advances in identifying familial hyperaldosteronism and aldosterone-producing adenoma mechanisms.
• Discussion of potential of genome-wide association studies for uncovering genetic susceptibility.

Main Results:

• Significant progress has been made in understanding the genetics of aldosterone-producing adenomas and familial hyperaldosteronism.
• Knowledge regarding the genetic underpinnings of bilateral adrenal hyperplasia remains limited.
• The genetic contribution to renin and aldosterone levels in the general population is poorly understood.

Conclusions:

• Further research into the genetics of bilateral adrenal hyperplasia is crucial.
• Genome-wide association studies hold promise for elucidating genetic susceptibility to primary aldosteronism.
• Understanding BAH genetics could lead to improved diagnostic and therapeutic strategies.